Abnova (Taiwan) (TPE:4133) Valuation Rank


TPE:4133 Abnova (Taiwan) Corp TPE:4133
75 GF Score
Price NT$20.85
GF Value NT$28.27
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Abnova (Taiwan) Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Abnova (Taiwan) Valuation Rank Related Terms

TPE:4133
75GF Score
Abnova (Taiwan) Corp TPE:4133
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Abnova (Taiwan) (TPE:4133) Overvalued in 2026?

Based on GuruFocus' analysis, Abnova (Taiwan) stock appears to be undervalued. The current stock price of NT$20.85 is trading 26.2% below its estimated GF Value™ of NT$28.27. GuruFocus considers Abnova (Taiwan) to be Modestly Undervalued.

Key valuation signals for TPE:4133:

  • Valuation Rank:
  • GF Value™: NT$28.27 vs. price of NT$20.85 (26.2% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the TPE:4133 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abnova (Taiwan) Business Description

Address No.108, Jhouzih Street, 9th Floor, Neihu District, Taipei City, TWN
Abnova (Taiwan) Corp is engaged in developing, manufacturing, and selling monoclonal antibody, polyclonal antibody, proteins, medical inspection instruments and testing reagents, which are mainly antibody reagents, antibody chips or related products provided to and used by academic, research institutions or pharmaceutical factories. Geographically, it operates in America, Europe, Taiwan and Other Countries. It generates maximum revenue from America. Its products include: SARS-CoV/CoV-2, DNA, RNA new, Proteins/peptides, MaxPab, DNAxPab, Polyclonal Ab, Monoclonal Ab and Others. The company's services are: Gene synthesis & cytogenetics, Peptide services, Protein expression, Humanized antibody, Assay development, Conjugation, FFPE tumor tissue DNA, In situ hybridization (ISH) and Others.
75GF Score

Get the complete analysis for TPE:4133

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.85
Price
NT$28.27
GF Value